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researchers to begin to fill in this gap. We have 3 specific comments about the article.
First, the authors' introduction states, "How frequently these and other prediction rules are being used in clinical practice is not known." This is certainly true of the vast majority of rules, but a fair bit is now known about the rules developed in Ottawa (2-5). Surveys of nationally representative samples of Canadian emergency physicians have shown that the Ottawa Ankle Rule is known to virtually all and is reportedly used by almost 90% of Canadian emergency physicians (2, 4), whereas international surveys show that this figure is dramatically different for other countries. For example, most U.S. emergency physicians were aware of this rule, but only 31% of them reported using it (3). This kind of data has been collected for the Ottawa Knee Rules (2) and the Canadian C-Spine Rule (5) and is currently being collected for the Canadian CT-Head Rule. Of note, self-reports of rule use tell us whether the physicians feel they make use of the rule but cannot tell us how the rule is used (for example, whether physicians are using the rule correctly and using it in all the circumstances for which it would be appropriate to do so). To address these issues, other techniques must be employed (4) .
Second, Reilly and Evans stress that clinical sensibility of the rule needs to be considered; any rule that does not make clinical sense will probably not be widely used. However, it is important to remember that clinical sensibility is, to some extent, idiosyncratic. Physician interviews about any specific rule are almost certain to elicit a wide variety of indicators that some feel would increase clinical sensibility. If there is general consensus that inclusion of a nonrule indicator would improve the safety or efficiency of the rule, then we agree that we should consider evaluating whether the indicator should be included in a modified rule, even at the relatively late stage of the impact analysis. However, if this new indicator results in a more effective rule, the new rule must then be revalidated in a sample larger than is typical for most impact analyses. Whenever possible, physicians should be consulted on all of the potentially useful indicators before the rule is derived, not after the impact analysis is conducted.
Even when all appropriate factors have been considered during rule derivation, some physicians who participate in the impact analysis will inevitably feel that the rule could be made safer, more efficient, or more clinically sensible if some of the other indicators were included. Indeed, we have found that many physicians purporting to use a rule will still consider factors known to add no more predictive value over the rule (4). We have argued that it may be useful to identify factors that were included when the rule was derived but excluded because they do not add anything; this approach might help to improve the perceived clinical sensibility of a rule and to clarify the level of appropriate use.
Third, Reilly and Evans correctly argue that addressing typical barriers to knowledge translation is a critical component to assessing the impact of a rule. Again, we contend that such issues should be considered well before the stage of impact analysis. For example, as the authors suggest, physicians are often more interested in sensitivity than specificity. Indeed, surveys suggest that many physicians would only consider using a rule that had extremely high sensitivity (2) . For this reason, the Ottawa Rules have typically adopted extremely high sensitivity thresholds. Although reducing the threshold sensitivity would clearly improve the specificity of the rule, our findings suggest that the increase in specificity would come at the cost of fewer physicians using the rule. To increase the chances of producing a rule that becomes widely used, such barriers should be considered well before the impact analysis stage and, ideally, very early in the development of the rule. 
CLINICAL OBSERVATIONS

Transrectal Methamphetamine Use: A Novel Route of Exposure
Background: With the widespread abuse of methamphetamine, its toxicity has been well described. The most common reported routes of exposure include intravenous injection, intranasal insufflation, smoking, and ingestion. To our knowledge, transrectal administration of methamphetamine has not been publicized in the medical literature.
Objective: To report a unique case of methamphetamine toxicity following a self-administered methamphetamine enema.
Case Report: A 29-year-old woman reported that she mixed between one half to 1 gram of methamphetamine with warm water in an oral syringe and instilled the contents into her rectum. Within minutes, she became anxious and experienced restlessness, palpitations, and tingling in her extremities. Paramedics were called, and the patient was transported to the emergency department. The patient weighed 81 kg; blood pressure was 226/160 mm Hg, pulse rate was 130 beats/min, respirations were 28 breaths/min, and oral temperature was 37.3°C. Immediately after administration of 3 mg of intravenous lorazepam, the patient's mental status and vital signs improved. Results of electrocardiography, blood chemistries, and complete blood count were normal; results of a urine toxicology screen were positive for amphetamines and tetrahydrocannabinol. She was admitted for observation and given a second dose of intravenous lorazepam. Her symptoms resolved completely over the next 20 hours without sequelae.
